Featured Stories
Record Job Satisfaction at Medis
This year for the first time we also measured the NetPromoterScore (NPS) index which was as high as 79%.
Read More
Medis ends its 2020 financial year with almost 12% revenue growth
Medis will continue its strategic investments to obtain high, double-digit, year-on-year growth and to reach the set financial goals for 2025.
Read More
We talked to Izolda Areskiene, Baltic States Regional Manager, Medis Pharma
Under her leaderhip Medis Pharma Lithuania has grown into a reliable, effective and profitable company with high ethical and compliance standards.
Read More
Interview with Aleksandar Spasovski, Country Manager of Medis in Bulgaria
Medis Pharma Bulgaria strives to improve the quality of life of patients by offering high-quality products.
Read More
Infected With Enthusiasm – Evolution of the Serbian Pharma Market
Medis is one of the fastest-growing pharmaceutical companies in Serbia. We talked to the Country Manager, Elina Markovic.
Read More
Country in Focus: Serbia
The total value of the pharmaceutical market in Serbia is € 833 million and it is estimated that it will grow by 6.7% from 2019 to 2021.
Read More